ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc., a company developing novel therapies for endocrine diseases caused by hormone dysregulation, today announced that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies 2016 Healthcare Conference on Wednesday, June 8th, 2016 at 1:30 p.m. ET in New York City.
